BRCA Mutation clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Sorry, in progress, not accepting new patients
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy.
Los Angeles, California and other locations
Our lead scientists for BRCA Mutation research studies include Gottfried Konecny.
Last updated: